Diagnostic performance and methodological concordance of the autologous sweat skin test for sweat allergy in a tropical setting: A pilot cross-sectional study
Asian Pacific Journal of Allergy and Immunology · 2025
DOI: 10.12932/ap-110625-2092 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Asian Pacific Journal of Allergy and Immunology, 2025. Verfasst von Teerapat Paringkarn und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Sweat, Skin Tests, Dermatitis, Atopic, Urticaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: Sweat allergy is frequently observed in patients with cholinergic urticaria (CholU) and atopic dermatitis (AD), yet data from high-sweating, tropical regions are scarce. The autologous sweat skin test (ASwST) is considered the reference diagnostic assay, but protocols differ. OBJECTIVE: To determine the prevalence of sweat allergy-assessed by the ASwST-in patients with CholU and AD in a tropical setting, and to evaluate concordance between the testing methods. METHODS: In this cross-sectional pilot study, 29 CholU patients, 41 AD patients, and 20 healthy controls underwent intradermal injection of filtered autologous sweat at 20 μL and 50 μL. Skin responses were assessed via wheal and flare formation. Positivity rate of sweat allergy using ASwST, clinical correlates, and inter-volume agreement were calculated. RESULTS: ASwST was positive in 8/29 CholU patients (27.6%) and 11/41 AD patients (26.8%); all controls were negative. In AD, positivity occurred across disease-severity strata. Overall inter-volume agreement reached 80%: 51/70 tests (72.9%) were negative for both volumes, and 5/70 (7.1%) were concordantly positive. The remaining 14/70 cases (20.0%) reacted only at 50 μL, yielding a significantly higher positivity rate than 20 μL (27.1% vs 7.1%, P = 0.001). CONCLUSIONS: In tropical Thailand, ASwST identified sweat allergy in approximately 25% of CholU and AD patients, lower than many temperate-zone reports. Either injection volume is acceptable; however, 50 μL increases diagnostic yield without compromising specificity. Larger, multicenter studies should clarify whether ambient heat, humidity, or cutaneous microbiota modulate sweat-allergy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Zitieren
APA
Paringkarn, T., Limphoka, P., Tuchinda, P., Chularojanamontri, L., Kanistanon, D., Phongtanthakun, W., Yenyuwadee, S., Saengthong-Aram, P., Ketyungyoenwong, A., Julraksa, M., Srinoulprasert, Y., & Kulthanan, K. (2025). Diagnostic performance and methodological concordance of the autologous sweat skin test for sweat allergy in a tropical setting: A pilot cross-sectional study. Asian Pacific Journal of Allergy and Immunology. https://doi.org/10.12932/ap-110625-2092
Vancouver
Paringkarn T, Limphoka P, Tuchinda P, Chularojanamontri L, Kanistanon D, Phongtanthakun W, et al. Diagnostic performance and methodological concordance of the autologous sweat skin test for sweat allergy in a tropical setting: A pilot cross-sectional study. Asian Pacific Journal of Allergy and Immunology. 2025. doi:10.12932/ap-110625-2092
BibTeX
@article{Paringkarn2025,
author = {Paringkarn, Teerapat and Limphoka, Pichaya and Tuchinda, Papapit and Chularojanamontri, Leena and Kanistanon, Duangjit and Phongtanthakun, Wanwisa and Yenyuwadee, Sasitorn and Saengthong-Aram, Phuwakorn and Ketyungyoenwong, Apichaya and Julraksa, Mananchaya and Srinoulprasert, Yuttana and Kulthanan, Kanokvalai},
title = {Diagnostic performance and methodological concordance of the autologous sweat skin test for sweat allergy in a tropical setting: A pilot cross-sectional study},
journal = {Asian Pacific Journal of Allergy and Immunology},
year = {2025},
doi = {10.12932/ap-110625-2092}
}
EUVIMED